Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
Pancreatology. 2022 Jan;22(1):112-122. doi: 10.1016/j.pan.2021.11.001. Epub 2021 Nov 3.
Whether coeliac axis resection (CAR) results from tumour topography or a prognostic factor for distal pancreatic ductal adenocarcinoma (PDAC) remains unclear. We aimed to compare the clinicopathological data between distal pancreatectomy with en bloc CAR (DP-CAR) and distal pancreatectomy plus splenectomy (DP-S) and analyse the prognostic factors.
We retrospectively analysed clinicopathological data from 102 patients who underwent distal pancreatectomy for PDAC and the factors affecting disease-free survival (DFS) and overall survival (OS). Of these patients, 45 and 57 underwent DP-CAR and DP-S, respectively.
DP-CAR was associated with more operative challenges than DP-S: more portomesenteric vein resections (48.9% vs. 14.0%), longer operations (320 vs. 242 min), and greater estimated blood loss (EBL) (600 vs. 200 ml). DP-CAR had larger tumours (5 vs. 4 cm), more perineural invasion (91.1% vs. 73.7%), and more microscopically positive surgical margins (20% vs. 3.5%), compared to DP-S. The major complication was clinically relevant postoperative pancreatic fistula (20.6%). The median DFS was 15.8 months and the median OS was 20.1 months. CAR was not associated with DFS or OS. EBL>700 ml, lymphovascular invasion (LVI), and adjuvant chemotherapy independently affected DFS and OS.
DP-CAR was associated with larger tumours and more surgical challenges but not with poorer DFS and OS than DP-S. CAR was more likely to result from tumour topography rather than from an adverse prognostic factor for resected distal PDAC. EBL>700 ml, LVI, and adjuvant chemotherapy were independent factors affecting the survival of patients with distal PDAC who underwent surgical resection.
空肠主干切除术(CAR)是由于肿瘤位置所致,还是远端胰腺导管腺癌(PDAC)的预后因素尚不清楚。我们旨在比较整块胰尾切除术伴 CAR(DP-CAR)和胰尾切除术加脾切除术(DP-S)的临床病理数据,并分析其预后因素。
我们回顾性分析了 102 例接受 PDAC 远端胰腺切除术的患者的临床病理资料,以及影响无病生存(DFS)和总生存(OS)的因素。其中 45 例患者行 DP-CAR,57 例行 DP-S。
与 DP-S 相比,DP-CAR 手术更具挑战性:更多的门静脉肠系膜切除术(48.9%比 14.0%)、更长的手术时间(320 分钟比 242 分钟)和更大的估计出血量(EBL)(600 毫升比 200 毫升)。与 DP-S 相比,DP-CAR 的肿瘤更大(5 厘米比 4 厘米),神经周围侵犯更多(91.1%比 73.7%),显微镜下阳性切缘更多(20%比 3.5%)。主要并发症为临床相关的术后胰瘘(20.6%)。中位 DFS 为 15.8 个月,中位 OS 为 20.1 个月。CAR 与 DFS 或 OS 无关。EBL>700ml、脉管侵犯(LVI)和辅助化疗是影响 DFS 和 OS 的独立因素。
与 DP-S 相比,DP-CAR 与更大的肿瘤和更多的手术挑战相关,但与 DP-S 相比,DFS 和 OS 无差异。CAR 更可能是由于肿瘤位置所致,而不是切除的远端 PDAC 的不良预后因素。EBL>700ml、LVI 和辅助化疗是接受手术切除的远端 PDAC 患者生存的独立因素。